2026-01-02 - Analysis Report
Okay, here's a breakdown and analysis of Hims & Hers Health Inc (HIMS) based on the data you provided.

**0) Report Overview**

This report analyzes the current state of HIMS stock, comparing its performance to the S&P 500 (VOO) and examining key financial indicators, recent news, and analyst opinions to provide a comprehensive overview.

**1) Return Rate Comparison**

*   **HIMS Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers a variety of health and wellness products and services directly to consumers.
*   **HIMS Cumulative Return:** 109.66%
*   **VOO Cumulative Return:** 75.26%
*   **Divergence:** 34.4 (Relative Divergence: 29.6)

**Analysis:** HIMS has significantly outperformed the S&P 500 since the start of the tracked period, with a cumulative return of 109.66% compared to the S&P 500's 75.26%. The divergence of 34.4 indicates that HIMS is currently outperforming VOO. However, a relative divergence of 29.6 suggests that while positive, the current divergence is not near its historical peak, indicating that there is no guarantee that HIMS will continue outperforming VOO.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD    | Alpha  | Beta | Cap(B) |
|------------|---------|--------|--------|------|--------|
| 2020-2022  | -36.0% | 86.1%  | -55.0% | 0.7  | 1.5    |
| 2021-2023  | -53.0% | 86.1%  | -82.0% | 1.6  | 2.0    |
| 2022-2024  | 395.0% | 79.6%  | 365.0% | 1.7  | 5.5    |
| 2023-2025  | 292.0% | 80.8%  | 224.0% | 2.1  | 7.4    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows volatile performance. Recent years (2022-2024 and 2023-2025) display very high growth rates.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk and price volatility.
*   **Alpha:** Alpha is a measure of risk-adjusted performance (performance relative to the market). The recent figures are extremely positive, implying strong outperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market (S&P 500). Beta values above 1 indicate that HIMS is more volatile than the market. Beta has been increasing, suggesting the stock is becoming more sensitive to market movements.
*   **Cap(B):** Market capitalization is steadily increasing, indicating the company is growing.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 32.47
*   **Last Market Data:** Price: 32.47, Previous Close: 33.04, Change: -1.73
*   **5-day SMA:** 33.718
*   **20-day SMA:** 36.247
*   **60-day SMA:** 41.9972

**Analysis:** The stock price is currently below all three moving averages (5-day, 20-day, and 60-day), indicating a short-term downtrend. The negative change from the previous close suggests continuing downward pressure.

**3) RSI, PPO, and Expected Return Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 17.05 (Oversold)
*   **PPO:** -0.46 (Bearish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (26 shares - Very Safe - MRI:0.90) Monthly invest 1.3% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -3.2 (Short-term decline)
*   **Expected Return (%):** 329.75

**Analysis:**

*   The RSI of 17.05 indicates that the stock is currently oversold, potentially suggesting a possible rebound.
*   The PPO being negative supports the downtrend seen in the moving averages.
*   The MRI suggests a relatively safer investment environment despite the volatility.
*   The Hybrid Signal recommends buying, based on the MRI score of 0.9.
*   The negative change in relative divergence confirms a recent short-term decline.
*   The high Expected Return (%) suggests significant potential upside if held long-term (over two years).

**4) Recent News & Significant Events**

*   **Negative Sentiment:** Several headlines point to valuation concerns and a recent losing streak for the stock ("HIMS Stock Falls," "$HIMS stock fell 6% this week").
*   **Valuation Discussion:** Articles discuss the stock's valuation after a pullback, indicating investors are re-evaluating the company.
*   **Share Repurchase Program:** The announcement of a $250 Million share repurchase program is generally positive as it signals the company believes its stock is undervalued.
*   **Ohio Buildout and Macro Calendar:** The article mentioning the Ohio buildout suggests the company is still investing in growth, while the reference to the macro calendar suggests external economic factors may be impacting investor sentiment.
*   **Positive 2025 Performance Mention:** The article "Why HIMS Stock Is Up 36% In 2025" provides a more positive outlook.

**4-2) Analyst Opinions**

*   **Consensus:** No clear consensus (Mean rating unavailable).
*   **Opinions:** 12 analysts providing ratings.
*   **Target Price:** Average: 44.67, High: 85.00, Low: 25.00

**Analysis:** The wide range in target prices (25.00 to 85.00) indicates considerable uncertainty and disagreement among analysts regarding the stock's future performance. The average target price of $44.67 suggests potential upside from the current price but should be viewed with caution given the wide range.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue  |
|------------|------|----------|
| 2025-11-03 | 0.07 | 0.60 B$  |
| 2025-08-04 | 0.19 | 0.54 B$  |
| 2025-05-05 | 0.22 | 0.59 B$  |
| 2024-11-04 | 0.35 | 0.40 B$  |
| 2025-11-03 | 0.35 | 0.40 B$  |

**Analysis:** EPS and revenue are varying, indicating volatile performance. Recent EPS figure is down while revenue increased, suggesting the profit margin is decreasing.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.60B  | 73.80%        |
| 2025-06-30   | $0.54B  | 76.39%        |
| 2025-03-31   | $0.59B  | 73.50%        |
| 2024-12-31   | $0.48B  | 76.81%        |
| 2024-09-30   | $0.40B  | 79.16%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE   |
|--------------|---------|-------|
| 2025-09-30   | $0.58B  | 2.72% |
| 2025-06-30   | $0.56B  | 7.55% |
| 2025-03-31   | $0.55B  | 9.01% |
| 2024-12-31   | $0.48B  | 5.46% |
| 2024-09-30   | $0.44B  | 17.18%|

**Analysis:**

*   **Revenue:** Revenue is generally increasing quarter-over-quarter, indicating growth in sales.
*   **Profit Margin:** Profit margins remain consistently high, suggesting good operational efficiency.
*   **Equity:** Equity is increasing, showing that the company's net worth is growing.
*   **ROE (Return on Equity):** ROE is fluctuating. The recent value is low, which could be a concern.

**7) Comprehensive Analysis**

**Summary:**

HIMS stock presents a mixed picture:

*   **Strengths:**
    *   High historical outperformance compared to the S&P 500.
    *   Strong revenue growth and high profit margins.
    *   Share repurchase program indicating company confidence.
    *   High expected return, suggesting long-term growth potential.

*   **Weaknesses:**
    *   Recent price decline and negative short-term trends (below moving averages).
    *   High volatility (high beta and maximum drawdown).
    *   Negative sentiment in recent news headlines related to valuation concerns.
    *   Low ROE recently.
    *   Decreasing profit margin.

**Conclusion:**

HIMS is a high-growth, high-risk stock. While it has shown significant outperformance in the past and has a high expected return, it is currently experiencing a period of negative sentiment and price decline. The oversold RSI may signal a potential rebound, but investors should be cautious due to the high volatility and valuation concerns. The wide range in analyst target prices indicates significant uncertainty. Investors should carefully consider their risk tolerance and conduct further research before investing in HIMS. The positive revenue growth and profit margins are encouraging, but the recent decrease in ROE warrants attention.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.